Tenon Medical Inc
NASDAQ:TNON

Watchlist Manager
Tenon Medical Inc Logo
Tenon Medical Inc
NASDAQ:TNON
Watchlist
Price: 0.7051 USD -11.07%
Market Cap: $7.6m

Wall Street
Price Targets

TNON Price Targets Summary
Tenon Medical Inc

Wall Street analysts forecast TNON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNON is 2.805 USD with a low forecast of 2.525 USD and a high forecast of 3.15 USD.

Lowest
Price Target
2.525 USD
258% Upside
Average
Price Target
2.805 USD
298% Upside
Highest
Price Target
3.15 USD
347% Upside
Tenon Medical Inc Competitors:
Price Targets
VIB3
Villeroy & Boch AG
33% Upside
H2A
H2APEX Group SCA
134% Upside

Revenue
Forecast

201% / Year
Past Growth
61% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
201% / Year
Past Growth
61% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

For the last 4 years the compound annual growth rate for Tenon Medical Inc's revenue is 201%. The projected CAGR for the next 4 years is 61%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-98%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-98%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNON's stock price target?
Price Target
2.805 USD

According to Wall Street analysts, the average 1-year price target for TNON is 2.805 USD with a low forecast of 2.525 USD and a high forecast of 3.15 USD.

What is Tenon Medical Inc's Revenue forecast?
Projected CAGR
61%

For the last 4 years the compound annual growth rate for Tenon Medical Inc's revenue is 201%. The projected CAGR for the next 4 years is 61%.

Back to Top